Stock C1P CONSUN PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Consun Pharmaceutical Group Limited Deutsche Boerse AG

Equities

C1P

KYG2524A1031

Market Closed - Deutsche Boerse AG
Other stock markets
 04:30:02 2024-04-26 am EDT 		5-day change 1st Jan Change
0.54 EUR -0.92% Intraday chart for Consun Pharmaceutical Group Limited -28.95% +1.89%
Mar. 28 Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 25 Consun Pharmaceutical Group Limited Announces Board and Committee Changes CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Consun Pharmaceutical Group Sees 15% Increase in 2023 Profit
MT
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024
CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue
MT
Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 20 September 2023
CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2022
CI
Consun Pharmaceutical Group Limited Declares Final Dividend for the Year Ended December 31, 2022
CI
Chinese Regulator Approves Consun Pharmaceutical's Clinical Trial for Kidney Disease Treatment
MT
Consun Pharmaceutical Group Limited Receives Approval for Clinical Trial of Drug for SK-07 Injection
CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Consun Pharmaceutical Group Limited Proposes to Pay A Final Dividend for the Year Ended December 31, 2022, Payable on or About June 21, 2023
CI
Consun Pharmaceutical Group Sees Surge in 2022 First-Half Profit
MT
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue
MT
Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Wanbangde Pharma in Talks to Buy Controlling Stake in Consun Pharma
MT
Consun Pharmaceutical Group Limited, A Wholly-Owned Subsidiary of Consun Pharmaceutical Co., Ltd Holds A Trial Production Ceremony in Plant No. 8, Area A05, Horgos Comprehensive Bonded Zone, Yili Kazakh
CI
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended December 31, 2021
CI
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on or About 17 June 2022
CI
Consun Pharma's Earnings Climb in 2021 on Higher Pharma Products Sales
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1681 Stock
  4. C1P Stock
  5. News Consun Pharmaceutical Group Limited
  6. Highlights